medigraphic.com
ISSN 1561-3062 (Electronic)

2020, Number 2

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2020; 46 (2)

Chlamydia trachomatis and its relationship with tubal infertility in sexually active women

Trujillo C, Moya-Salazar J, Rodríguez U, Florian L, Contreras-Pulache H

Language: Spanish
References: 22
Page: 1-12
PDF size: 318.62 Kb.


ABSTRACT

Introduction: Chlamydia trachomatis is the main bacterial pathogen widely associated with tubal infertility.
Objectives: To determine the association between Chlamydia trachomatis infection and tubal infertility in sexually active women treated at the Human Reproduction Service, Dos de Mayo National Hospital, Lima, Peru and to highlight their sociodemographic and sexual behavior characteristics.
Methods: A prospective cross-sectional study was designed in sexually active women between 18 and 49 years of age, who had pelvic inflammatory disease, pelvic pain, cervicitis, dyspareunia, vaginal discharge, and painful urination. Sixty-seven women formed the sample, and those who had surgical tubal blockage, or were undergoing treatment during the previous four weeks, were excluded. Chlamydia trachomatis IgM was used by 4th generation ELISA.
Results: The sixty-seven women studied had an average age of 34 ± 8 years, where the most represented age group was 31 to 40 years (35.8%), 24 women (35.8%) were married and 30 (44.7%) got higher university education. Sixteen women (23.8%) had primary infertility and 12 (17.9%) had secondary infertility. Tubal damage was present in 21 women (31.3%), and 12 of them (17.9%) had bilateral tubal occlusion. Out of the 31 women with pelvic inflammatory disease, 19 (61.2%) had Chlamydia trachomatis infection, which showed a relationship between both pathologies. Anti-Chlamydia trachomatis antibodies were positive in 30 patients (44.8%), 9 of which (13.5%) had tubal occlusion. No association was found between Chlamydia trachomatis infection and tubal infertility.
Conclusions: This study did not determine the association between Chlamydia trachomatis infection and tubal infertility with bilateral occlusion, nor with some significant risk determinants such as history of pelvic inflammatory disease.


REFERENCES

  1. Malogajsky J, Brankovic I, Land JA, Thomas PP, Morre SA, Ambrosino E. The potential role for host genetic profiling in screening for Chlamydia – Associated tubal factor infertility (TFI) – New perspectives. Genes 2019;10:410. DOI: http://10.3390/genes10060410

  2. Brugo Olmedo S, Chillik C, Kopelman S. Definición y causas de la infertilidad. Rev Colombiana Obstet Ginecol. 2003;54(4).

  3. Sattari M, Ghiamia M, Ghasemzadeh A, Mohammadoghli Z. Frequency of anti–Chlamydia Trachomatis antibodies in infertile women referred to Tabriz Al- Zahra hospital. Int J Reprod Bio Med. 2017;15(1):17-20.

  4. Organización Mundial de la Salud. Infecciones de transmisión sexual. WHO news. [Internet] [citado 30/12/2019]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/sexually-transmitted-infections-(stis)

  5. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117 (Suppl 2): 5-10. DOI: http://10.1016/j.ygyno.2010.01.024

  6. Beyuo T, Oppong S, Samba A, Beyuo V. Chlamydia Trachomatis infection among Ghanian women undergoing hysterosalpingography for suspected tubal factor infertility. Int J Gynecol Obstet. 2019;146:200-5. DOI: http://10.1002/ijgo.12875

  7. Peña AB, Bonachea R, Beltrán E, Echemendía D, Beltrán E, Fernández Álvarez M. Chlamydia trachomatis en mujeres infértiles. Daños y consecuencias. Rev Cubana Obstet Ginecol. 2019;45(2):1-19.

  8. Aprobatto F, Aprobatto M, Maia M, De Lima Y, Barbosa M, Benetti B. Bilateral but not unilateral tubal obstruction is associated with positive chlamydia serology. JBRA Assisted Reproduction. 2020;24(1):20-3. DOI: http://10.5935/1518-0557.20190049

  9. Singh S, Bhandari S, Agarwal P, Chittawar P, Thakur R. Tha Chlamydia antibody test helps identify women with possible tubal factor infertility. Int J Reprod BioMed. 2016;14 (3):187-92.

  10. Joya M, Joya A, Sequera M, Areaga E. Infertilidad e infección por Chlamydia trachomantis en mujeres sexualmente activas del estado Carabobo, Venezuela. Rev Med Risaralda. 2014;20(1):24-8. DOI: http://dx.doi.org/10.22517/25395203.8753

  11. Talaro PC, Talaro A. Foundations in Microbiology. 4th ed. New York: Mc Graw-Hill; 2002.

  12. Panatto D, Amicizia D, Bianchi S, Frati ER, Zotti CM, Lai PL. Chlamydia trachomatis prevalence and chlamydial/HPV co-infection among HPV-unvaccinated young Italian females with normal cytology. Hum Vaccin Immunother. 2015;11(1):270–6. DOI: http://10.4161/hv.36163

  13. Janssen KJH, Dirks JAMC, Dukers-Muijrers NHTM, Hoebe CJPA, Wolffs PFG. Review of Chlamydia trachomatis viability methods: assessing the clinical diagnostic impact of NAAT positive results. Expert Rev Mol Diagn. 2018;18(8):739-47. DOI: http://10.1080/14737159.2018

  14. Cancino R, Pacheco G, Rodríguez D, Rechkemmer A. Infertilidad por Salpingitis: características demográficas y clínicas de pacientes atendidas en el Hospital Arzobispo Loayza Lima – Perù. Ginecol Obstet. 2002;48(3). DOI: https://doi.org/10.31403/rpgo.v48i534

  15. García P. Tamizaje y tratamiento de Chlamydia Trachomatis en gestantes en Lima, Perú. Rev Per Invest Materno Perinatal. 2014;3(1):33-8.

  16. Moreno I, Simon C. Relevance of assessing the uterine microbiota in infertility. Fertil Steril. 2018;110(3):337-43. DOI: https://doi.org/10.1016/j.fertnstert.2018.04.041

  17. Łaniewski P, Cui H, Roe DJ, Barnes D, Goulder A, Monk BJ, et al. Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis. Sci Rep. 2019;9:7333. DOI: https://doi.org/10.1038/s41598-019-43849-5

  18. Nemolato ARM, Moya-Salazar J. The possible role of microbiome in gastric cancer: perspectives. EC Gastroenterology and Digestive System. 2018;5(5):328-31.

  19. Moreno I, Codoñer FM, Vilella F, Valbuena D, Martínez-Blanch JF, Jiménez-Almazán J, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703. DOI: https://doi.org/10.1016/j.ajog.2016.09.075

  20. Silva MSB, Giacobini P. Don't Trust Your Gut: When Gut Microbiota Disrupt Fertility. Cell Metab. 2019;30(4):616-8. DOI: https://doi.org/10.1016/j.cmet.2019.09.005

  21. Tamrakar R, Yamada T, Furuta I, Cho K, Morikawa M, Yamada H, et al. Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis. 2007;7(3):128.

  22. Chao XP, Sun TT, Wang S, Fan QB, Shi HH, Zhu L, et al. Correlation between the diversity of vaginal microbiota and the risk of high-risk human papillomavirus infection. Int J Gynecol Cancer. 2019;29(1):28-34. DOI: https://doi.org/10.1136/ijgc-2018-000032




2020     |     www.medigraphic.com